Clinical Trials Logo

Clinical Trial Summary

In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated,since it does not take into account people who are untreated or not diagnosed. However,it is estimated that 20 to 30% of adults with diabetes do not are not diagnosed. Conclusions presented during the annual meeting of the european Association for the Study of diabetes (EASD-Berlin) from 2019 suggest that signs precursors of the disease would be present up to 20 years before the diagnosis. The Diagnosis is usually made around 40-50 years. The main factor of risk of T2D is the lifestyle, in particular a diet too rich for a too sedentary daily life. From a medico-economic point of view, chronic pathologies (including diabetes) account for 60% of insurance expenditure illness even though they concern 35% of insured persons, i.e. 20 million patients. The average annual repayment of a type 2 diabetic patient is 4890 euros. This study is part of this context as the starting point a reflection on a different, coordinated management, to know a preventive rather than a curative approach.


Clinical Trial Description

In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated. since it does not take into account people who are untreated or not diagnosed. However, given the silent nature of the disease, it is estimated that 20 to 30% of adults with diabetes do not are not diagnosed. This share decreases with age, falling to 13% among 55-74 year olds. Conclusions presented during the annual meeting of the european Association for the Study of diabetes (EASD-Berlin) from 2019 suggest that signs precursors of the disease would be present up to 20 years before the diagnosis. Type 2 diabetes, or non-insulin dependent diabetes, is a metabolic disease characterized by a chronic excess of sugar in the blood, affecting both men and women. the Diagnosis is usually made around 40-50 years. The main factor of risk of T2D is the lifestyle, in particular a diet too rich for a too sedentary daily life. The direct consequences are an increase in obesity hich is itself a major risk factor for the development of T2D. Among the risk factors, we also find hyperlipidemia, high blood pressure, high blood sugar fasting, stress, smoking, heredity, family history of diabetes, or gestational diabetes. From a medico-economic point of view, chronic pathologies (including diabetes) account for 60% of insurance expenditure illness even though they concern 35% of insured persons, i.e. 20 million patients. The average annual repayment of a type 2 diabetic patient is 4890 euros.This study is part of this context as the starting point a reflection on a different, coordinated management, to know a preventive rather than a curative approach. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05325710
Study type Interventional
Source Ramsay Générale de Santé
Contact JF OUDET
Phone 068346567
Email jf.oudet@ecten.eu
Status Recruiting
Phase N/A
Start date March 20, 2022
Completion date April 1, 2028

See also
  Status Clinical Trial Phase
Recruiting NCT04940962 - Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion N/A
Completed NCT05359341 - Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients? N/A
Recruiting NCT04700813 - Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications
Completed NCT05413330 - Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes. Phase 2/Phase 3
Recruiting NCT04927377 - Accessible and Inclusive Diabetes Telecoaching Self-Management Program N/A
Completed NCT05585268 - Electronic Decision Support for Deprescribing in Patients on Hemodialysis N/A
Active, not recruiting NCT05088616 - Native American Diabetes Project N/A
Not yet recruiting NCT03273738 - Vascular and Metabolic Changes in Postmenopausal Diabetics
Active, not recruiting NCT04642911 - Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy
Withdrawn NCT04283617 - Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study N/A
Recruiting NCT04769687 - Symbiotics and Systemic Inflammation in Chronic Kidney Disease Phase 2
Withdrawn NCT06104358 - Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes Phase 2
Recruiting NCT03341793 - Impact of Changes in Muscle Secretome in the Remission of Type 2 Diabetes Mellitus Induced by Bariatric Surgery N/A
Not yet recruiting NCT06080802 - The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction Phase 2/Phase 3
Recruiting NCT04485845 - Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression Phase 4
Recruiting NCT05050500 - The Effect of Dapagliflozin on the Short-term Prognosis of Patients With Acute Myocardial Infarction Phase 4
Completed NCT04115657 - The Effect of Different Starches of Boba Pearls and Sugar Substitutes Used in Milk Tea on Glycaemia, Insulinaemia and Appetite Control (Pearl Study) N/A
Completed NCT06188572 - The Effect of Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality
Completed NCT04120844 - Effectiveness of Motivational Interviewing on Improving Care for Type 2 Diabetes Mellitus Patients in China N/A
Completed NCT05789706 - Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans N/A